• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与葡萄膜炎相关的青光眼。

Glaucoma associated with uveitis.

作者信息

Moorthy R S, Mermoud A, Baerveldt G, Minckler D S, Lee P P, Rao N A

机构信息

Doheny Eye Institute, University of Southern California School of Medicine, Los Angeles, USA.

出版信息

Surv Ophthalmol. 1997 Mar-Apr;41(5):361-94. doi: 10.1016/s0039-6257(97)00006-4.

DOI:10.1016/s0039-6257(97)00006-4
PMID:9163835
Abstract

Raised intraocular pressure is a common and frequently serious complication of anterior uveitis. The milieu of inflammatory cells, the mediators they release, and the corticosteroid therapy used to treat the uveitis can participate in the pathogenesis of uveitic glaucoma. These factors alter the normal anatomic structure of the anterior chamber and angle, influencing aqueous production and outflow. These changes act to disrupt the homeostatic mechanisms of intraocular pressure control. Structural changes in the angle can be acute, such as in secondary angle closure with pupillary block glaucoma, or chronic, such as combined steroid-induced and secondary open angle glaucoma. Management of uveitic glaucoma may be difficult because of the numerous mechanisms involved in its pathogenesis. Diagnostic and therapeutic decisions are guided by careful delineation of the pathophysiology of each individual case. The goal of treatment is to minimize permanent structural alteration of aqueous outflow and to prevent damage to the optic nerve head. This article reviews the pathogenesis of uveitic glaucoma, with specific attention to etiology. Medical and surgical therapies are also discussed, with emphasis on the more recent developments in each category.

摘要

眼压升高是前葡萄膜炎常见且往往较为严重的并发症。炎症细胞的环境、它们释放的介质以及用于治疗葡萄膜炎的皮质类固醇疗法都可能参与葡萄膜炎性青光眼的发病机制。这些因素改变了前房和房角的正常解剖结构,影响房水的生成和流出。这些变化会破坏眼压控制的稳态机制。房角的结构变化可以是急性的,如瞳孔阻滞性青光眼继发的房角关闭,也可以是慢性的,如类固醇诱导性和继发性开角型青光眼合并存在。由于葡萄膜炎性青光眼发病机制涉及多种因素,其治疗可能较为困难。诊断和治疗决策需依据对每个病例病理生理学的仔细剖析来指导。治疗的目标是尽量减少房水流出的永久性结构改变,并防止对视神经乳头造成损害。本文回顾了葡萄膜炎性青光眼的发病机制,特别关注病因。还讨论了药物和手术治疗方法,重点介绍了每一类别的最新进展。

相似文献

1
Glaucoma associated with uveitis.与葡萄膜炎相关的青光眼。
Surv Ophthalmol. 1997 Mar-Apr;41(5):361-94. doi: 10.1016/s0039-6257(97)00006-4.
2
[Physiopathology of uveitic glaucoma].[葡萄膜炎性青光眼的病理生理学]
Klin Monbl Augenheilkd. 1997 May;210(5):269-73. doi: 10.1055/s-2008-1035052.
3
Current Approach in the Diagnosis and Management of Uveitic Glaucoma.葡萄膜炎性青光眼的诊断与治疗现状
Biomed Res Int. 2015;2015:742792. doi: 10.1155/2015/742792. Epub 2015 Oct 19.
4
Current management of uveitis-associated ocular hypertension and glaucoma.葡萄膜炎相关性眼压升高和青光眼的当前治疗方法。
Surv Ophthalmol. 2020 Jul-Aug;65(4):397-407. doi: 10.1016/j.survophthal.2019.12.003. Epub 2019 Dec 6.
5
Uveitic glaucoma.葡萄膜炎性青光眼
Ophthalmol Clin North Am. 2002 Sep;15(3):375-87, viii. doi: 10.1016/s0896-1549(02)00028-7.
6
[Glaucoma and uveitis. Causes of and treatment options for increased intraocular pressure in cases of inflammatory ophthalmology].[青光眼与葡萄膜炎。炎症性眼科疾病中眼压升高的原因及治疗选择]
Ophthalmologe. 2003 Nov;100(11):991-1006; quiz 1007-8. doi: 10.1007/s00347-003-0831-1.
7
Glaucoma in patients with ocular inflammatory disease.眼部炎性疾病患者的青光眼
Ophthalmol Clin North Am. 2005 Sep;18(3):421-30, vii. doi: 10.1016/j.ohc.2005.05.004.
8
Overcoming diagnostic and treatment challenges in uveitic glaucoma.克服葡萄膜炎性青光眼的诊断和治疗挑战。
Clin Exp Optom. 2019 Mar;102(2):109-115. doi: 10.1111/cxo.12811. Epub 2018 Jul 29.
9
PATHOGENESIS AND CURRENT METHODS OF TREATMENT OF SECONDARY UVEITIC GLAUCOMA. A REVIEW.继发性葡萄膜炎性青光眼的发病机制与治疗方法研究进展。综述。
Cesk Slov Oftalmol. 2023 Spring;79(3):111-115. doi: 10.31348/2023/7.
10
Aetiology and clinical characteristics of uveitic glaucoma in Turkish patients.土耳其患者葡萄膜炎相关性青光眼的病因和临床特征。
Int Ophthalmol. 2021 Jun;41(6):2225-2234. doi: 10.1007/s10792-021-01783-4. Epub 2021 Mar 17.

引用本文的文献

1
A rare case of membrane pupillary-block glaucoma in a phakic eye with uveitis.一例罕见的伴有葡萄膜炎的有晶状体眼膜性瞳孔阻滞性青光眼。
BMC Ophthalmol. 2025 Jul 1;25(1):358. doi: 10.1186/s12886-025-04191-9.
2
Association of Eye Drop-Treated Diseases and Conditions That Can Impair Eye Drop Self-Administration.滴眼液治疗的疾病与可能损害滴眼液自我给药能力的病症之间的关联。
Ophthalmol Glaucoma. 2025 Apr 8. doi: 10.1016/j.ogla.2025.04.001.
3
Prevalence and Risk Factors for Ocular Complications in New-Onset Uveitis: A Study From a Tertiary Referral Center in Northern Thailand.
新发葡萄膜炎眼部并发症的患病率及危险因素:来自泰国北部一家三级转诊中心的研究
Clin Ophthalmol. 2025 Feb 14;19:543-551. doi: 10.2147/OPTH.S500339. eCollection 2025.
4
Multiple cytokine analysis of aqueous humor in uveitis with or without secondary glaucoma.葡萄膜炎伴或不伴继发性青光眼房水中的多种细胞因子分析。
BMC Ophthalmol. 2024 Oct 15;24(1):451. doi: 10.1186/s12886-024-03691-4.
5
Cytomegalovirus retinitis with panretinal occlusive vasculopathy concealed by hypertensive uveitis: a case report.巨细胞病毒性视网膜炎伴全视网膜闭塞性血管病变被高血压性葡萄膜炎掩盖:一例报告
J Yeungnam Med Sci. 2024 Oct;41(4):300-305. doi: 10.12701/jyms.2024.00584. Epub 2024 Aug 30.
6
Overview of Cytomegalovirus Ocular Diseases: Retinitis, Corneal Endotheliitis, and Iridocyclitis.巨细胞病毒眼病概述:视网膜炎、角膜内皮炎和虹膜睫状体炎。
Viruses. 2024 Jul 11;16(7):1110. doi: 10.3390/v16071110.
7
Prevalence and clinical characteristics of uveitic glaucoma: multicentric study in Bogotá, Colombia.葡萄膜炎相关性青光眼的患病率及临床特征:哥伦比亚波哥大的一项多中心研究。
Eye (Lond). 2024 Mar;38(4):714-722. doi: 10.1038/s41433-023-02757-9. Epub 2023 Oct 3.
8
Glaucoma and Systemic Disease.青光眼与全身性疾病
Life (Basel). 2023 Apr 15;13(4):1018. doi: 10.3390/life13041018.
9
"Ab Interno" Surgery of the Schlemm's Canal in Postuveitic Glaucoma Patients.葡萄膜炎性青光眼患者施莱姆管的内路手术
J Pers Med. 2023 Feb 28;13(3):456. doi: 10.3390/jpm13030456.
10
Overview and update on cytomegalovirus-associated anterior uveitis and glaucoma.巨细胞病毒相关性前葡萄膜炎和青光眼的概述及最新进展。
Front Public Health. 2023 Mar 1;11:1117412. doi: 10.3389/fpubh.2023.1117412. eCollection 2023.